|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Net Revenues | |||||
| Product | |||||
| Recurring | |||||
| Total Net Revenues | |||||
| Cost of Sales | |||||
| Product | |||||
| Recurring | |||||
| Total Cost of Sales | |||||
| Gross Profit | |||||
| Operating Expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Depreciation and amortization | |||||
| Total Operating Expenses | |||||
| Operating (Loss) | |||||
| Other Income / (Expenses): | |||||
| Gain on Debt Extinguishment | |||||
| (Loss) on Fixed Assets Disposal | |||||
| Interest expense, net | |||||
| Total Other Income / (Expenses): | |||||
| Loss before Provision for Income Taxes | |||||
| (Loss) before Provision for Income Taxes | |||||
| Income Tax Provision | |||||
| Gain from sale of discontinued operations (net of tax) | |||||
| Net (Loss) | |||||
| Net (Loss) per Common Share: | |||||
| Basic – net income (loss) attributable to common stockholders | |||||
| Diluted – net income (loss) attributable to common stockholders | |||||
| Weighted Average Common Shares Outstanding – basic | |||||
| Weighted Average Common Shares Outstanding – diluted | |||||
Loading...